The Fed made the right call in hitting pause this week. "I'm not sure that pausing is really all the bad for stocks in the ...
Palantir consistently positions itself as a leader in enterprise-level artificial intelligence. It has also secured strong ...
With a rise in Trikafta demand, the investors have assigned a higher valuation multiple for VRTX stock. The increase in VRTX ...
Super Micro shares continue their march downwards, down 40%+ in the last 12 months. Click here to read an analysis of SMCI ...
Thursday's coverage included more tech earnings, focus on Trump's latest on potential tariffs and more analysis around Monday ...
DeepSeek Launch, Intel’s Price Cuts The unveiling of China’s new resource-light AI model, DeepSeek, roiled the U.S. big ...
Given the natural desire to pick up market discounts, it’s easy to fall into the trap of simply buying AMD stock at the sight ...
Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.
Tesla Inc.’s quarterly results this week drove home the lesson that profit and sales numbers don’t seem to matter much for ...
The EV maker's shares have formed a new trading range. Something dramatic will need to happen to snap them out of it.